Fundraising Fox

Find the right investors for your startup

A free, open database of 27,102 venture funds and 123,058 investors — searchable by stage, sector, and location. No login required.

Tracking the funds you know

Deal radar

Fresh SEC Form D filings our pipeline links to tracked companies and investors — often days before the news breaks. A Form D is the short notice a company or fund must file within 15 days of taking its first money, so it names the amount, the count of investors, and the officers and directors behind the raise.

  • Sep 1, 2026 · Miami, FL · Other Technology

    $87.8Mraised

    Felix Technologies (Félix Pago) runs a chat-based platform for cross-border remittances from the US to Latin America.

    Felix Technologies told the SEC it has taken in $87.8M from 16 investors, with the first money in on Jun 29, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 3 of the 4 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

  • Sep 1, 2026 · Monmouth Junction, NJ · Other Technology

    $8.3Mraised of $10M

    Orthobond develops proprietary antimicrobial nanosurface technology that covalently binds to metallic and polymeric surfaces to mechanically kill bacteria, viruses, and fungi without antibiotics or eluting chemicals. Its first products, including Ostaguard, are antimicrobial surface treatments for implantable medical devices, with intended future applications in textiles, consumer goods, and high-touch public surfaces.

    Orthobond told the SEC it has taken in $8.3M of a $10M round from 24 investors, with the first money in on Aug 24, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement.

    On the filing
  • Sep 1, 2026 · Cheyenne, WY · Other Technology

    $1.5Mraised

    Language IO offers an AI-powered real-time translation platform that plugs into existing customer support systems (CRM, browser) to let agents communicate with customers in 150+ languages. It targets enterprise customer support teams in regulated sectors such as finance, healthcare, and government, with an emphasis on data security and compliance (GDPR, HIPAA).

    Language I/O told the SEC it has taken in $1.5M from 26 investors, with the first money in on Aug 3, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 1 of the 6 people it names is a partner at a firm we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

    Founder
    Heather Shoemaker
    On the filing
  • Sep 1, 2026 · New York, NY · Other Technology

    $100.1Mraised

    Gnau Inc. told the SEC it has taken in $100.1M from 22 investors, with the first money in on Aug 18, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 3 of the 4 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

  • Aug 31, 2026 · New York, NY · Other Technology

    $175.3Mraised of $175.4M

    Serverless cloud platform that runs Python-defined, compute-intensive AI and ML workloads on elastic CPU and GPU capacity.

    Modal Labs, Inc. told the SEC it has taken in $175.3M of a $175.4M round from 17 investors, with the first money in on May 15, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 2 of the 4 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

    Founders
    Akshat BubnaErik Bernhardsson
  • Conavi Medical

    Aug 31, 2026 · Toronto, A6 · Other Health Care

    $3.5Mraised

    Conavi Medical told the SEC it has taken in $3.5M from 12 investors, with the first money in on Aug 12, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement.

    On the filing
    Thomas LoobyMark QuickCraig PodolskyAaron DavidsonRobert D Mitchell
  • Aug 31, 2026 · San Francisco, CA · Other Technology

    $40Mraised

    AI software-validation platform that indexes full codebases, reviews and security-checks pull requests, learns team standards, and runs changed code in sandboxes through its TREX execution agent.

    Tabnam told the SEC it has taken in $40M from 11 investors, with the first money in on Aug 14, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 2 of the 5 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

  • Aug 31, 2026 · Chicago, IL

    $3Boffered

    ARCH Venture Fund XIV, L.P. is a pooled investment vehicle — a fund raising from its own backers, not a startup round. It is raising $3B. 4 of the 7 people it names are partners at firms we track.

  • Aug 31, 2026 · New York, NY · Other Technology

    $1Mraised

    Ranger RFX told the SEC it has taken in $1M from 4 investors, with the first money in on Jul 6, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 2 of the 3 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

  • Aug 28, 2026 · Los Angeles, CA

    $10Mraised

    Upfront Secondary II-C, L.P. is a pooled investment vehicle — a fund raising from its own backers, not a startup round. It has closed $10M from 3 investors. 2 of the 3 people it names are partners at firms we track.

  • GAPCO Wavebreak Secondaries Fund I (Bermuda), L.P.fund vehicle

    Aug 28, 2026 · New York, NY

    GAPCO Wavebreak Secondaries Fund I (Bermuda), L.P. is a pooled investment vehicle — a fund raising from its own backers, not a startup round. It reported a new raise. 3 of the 6 people it names are partners at firms we track.

  • Aug 28, 2026 · Woburn, MA · Biotechnology

    $2.3Mraised

    Aegle Therapeutics develops therapies using extracellular vesicles (EVs) isolated from mesenchymal stem cells to deliver therapeutic biomolecules to diseased and damaged cells. Its lead product, AGLE-102, targets dystrophic epidermolysis bullosa, a rare pediatric skin-blistering disease, with potential applications across dermatology, immunology, and protein-deficiency disorders.

    Aegle Therapeutics told the SEC it has taken in $2.3M from 17 investors, with the first money in on Aug 4, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 1 of the 4 people it names is a partner at a firm we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

    Founders
    Shelley A. HartmanEvangelos V. Badiavas
    On the filing
  • Aug 28, 2026 · Manchester, NH · Investing

    $27.4Mraised of $36M

    Alumni Ventures runs Investing Clubs that bring together small groups of 15-20 accredited investors sharing a common identity — such as university affiliation, industry, profession, or region — to review one vetted venture deal per month while each member makes their own investment decisions. The clubs give members access to Alumni Ventures' institutional venture pipeline, with deals co-invested alongside firms like Sequoia, a16z, and Kleiner Perkins.

    Alumni Ventures told the SEC it has taken in $27.4M of a $36M round from 540 investors, with the first money in on Aug 13, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 4 of the 7 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

    Founders
    James GillMichael CollinsBeth ObermillerLuke Antal
  • Aug 28, 2026 · Blacksburg, VA · Other

    $505Kraised of $1.3M

    Qentoros develops peptide biologic therapeutics for veterinary medicine through its Q-Biologics platform, with the first product BIO-PLY™ in FDA development for infectious, inflammatory, and degenerative diseases.

    Qentoros told the SEC it has taken in $505K of a $1.3M round from 9 investors, with the first money in on Apr 24, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 2 of the 4 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

    Founder
    Jessica Gilbertie

From public SEC filings; automated matching — filings are facts, interpretations are estimates. See how we read these: the Airtable × Bending Spoons waterfall → The DroneDeploy × Procore waterfall → Every recent raise →

Popular investor lists